Protective effect of the calcium channel blocker diltiazem on hepatic function following warm ischemia

Author(s): Hisanaga M, Nakajima Y, Wada T, Kanehiro H, Fukuoka T, et al.


The purpose of this study was to investigate the protective effect of a calcium channel blocker diltiazem (DTZ) on hepatic ischemic injury using a canine model. Hepatic ischemia was induced by temporary clamping of hepatic afferent blood vessels for 60 min with establishment of a portojugular bypass. The administration of DTZ at a dose of 70 micrograms/kg bolus i.v. injection before hepatic ischemia and thereafter via the portal vein at a dose of 10 micrograms/kg/min well restored the hepatic blood flow (HBF, 92 +/- 5%; P < 0.01) and arterial ketone body ratio (AKBR, 1.15 +/- 0.16; P < 0.01) 1 hr after interruption compared with untreated controls (HBF, 61 +/- 7%; AKBR, 0.53 +/- 0.09). In addition, the increase of plasma lactate level and the decrease of mean arterial pressure were significantly suppressed after ischemia (P < 0.05). We concluded that DTZ has a protective effect on ischemia-induced hepatic damage and might be useful in the prevention of primary graft failure caused by warm ischemia in liver transplantation.

Similar Articles

Protective effects of calcium channel blockers in carbon tetrachloride-induced liver toxicity

Author(s): Romero G, Lasheras B, Sainz Suberviola L, Cenarruzabeitia E

Protective effect of diltiazem against acetaminophen hepatotoxicity in mice

Author(s): Satorres J, Perez-Mateo M, Mayol MJ, Esteban A, Graells ML

The use of silymarin in the treatment of liver diseases

Author(s): Saller R, Meier R, Brignoli R